Brainomix’s e-Lung software is powered by unique imaging biomarkers that have demonstrated superior prognostic value compared with traditional measures in both non-IPF and IPF ILD patients.
The e-Stroke platform was nominated in the category of "Best Digital Health Solution," recognizing its transformative impact stroke care.
Recognized as one of the most innovative companies in Europe, Brainomix is attracting the attention of leading tech investors
2020 was marked by a global pandemic – but also saw significant progress and innovation
Brainomix software to be featured in a number of scientific presentations and posters
We'd like to introduce you to the new Brainomix identity, which reflects our company's world-class expertise and focus on delivering cutting-edge AI solutions for better treatment decisions.
An update on some of the exciting developments from the first half of 2020
Brainomix committed to working with clinicians to make life-saving treatments accessible to all stroke patients
Event focused on NHS Long Term Plan and the role of AI solutions
Brainomix invites you to join us at ESOC 2019 to experience first-hand the most comprehensive imaging solution
Brainomix will be exhibiting at the 14th Congress of the World Federation of Interventional and Therapeutic Neuroradiology
Brainomix will be participating at the 3rd European Stroke Conference (ESOC 2017)
Brainomix will be attending the Annual Meeting of the German & Austrian Stroke Society
Will be attending the neuroradiology event in Cologne
Brainomix is attending the 2016 European Stroke Organization Conference in Barcelona
Brainomix is attending this year’s ECR 2016 - European Congress of Radiology in Vienna